Results 161 to 170 of about 763,886 (286)

Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell-derived neural crest cells. [PDF]

open access: yesCancer Sci, 2023
Mukae K   +12 more
europepmc   +1 more source

Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology [PDF]

open access: hybrid, 2000
Véronique Minard‐Colin   +21 more
openalex   +1 more source

Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.

open access: yesJournal of Clinical Oncology, 2008
PURPOSE MYCN amplification is rarely detected in patients with favorable-stage neuroblastoma (NB). To determine the clinical significance of MYCN amplification in children with favorable-stage NB, we performed a retrospective review of data from the ...
J. Schneiderman   +5 more
semanticscholar   +1 more source

Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification

open access: yesBritish Journal of Cancer, 2007
Whereas neuroblastoma (NB) with MYCN amplification presents a poor prognosis, no single marker allows to reliably predict outcome in tumours without MYCN amplification.
G. Schleiermacher   +15 more
semanticscholar   +1 more source

Cascaded Weak Measurements Amplification of Ultra-small Phases [PDF]

open access: yesarXiv, 2017
The weak measurements based amplification of ultra-small phase was proposed in our previous work. Due to the technical imperfections, the ability of amplification is usually limited in practice. Here we introduce the concept of cascaded weak measurements amplification so that the ability of weak measurements amplification can be further improved.
arxiv  

c‐Kit is preferentially expressed in MYCN‐amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI‐571 [PDF]

open access: bronze, 2003
Roberta Vitali   +8 more
openalex   +1 more source

Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction.

open access: yesJournal of Clinical Oncology, 2005
PURPOSE MYCN amplification (MNA) indicates a poor prognosis in neuroblastoma (NB) and is routinely assayed for therapy stratification. We aimed to develop a diagnostic tool to predict MYCN status using serum DNA, which, in cancer patients, predominantly ...
T. Gotoh   +9 more
semanticscholar   +1 more source

cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma [PDF]

open access: gold, 2004
Qing-Rong Chen   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy